SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Henry Niman who wrote (19541)4/24/1998 11:26:00 AM
From: John O'Neill  Read Replies (1) | Respond to of 32384
 
Henry...LGND is going for the fast track on P-gel and Targretin.....

Do you have a guestimate on how much LGND would know now about the off label potential for these? IE, could they be well aware that P-gel is very effective for TX of a particular condition and expect main revenue for that application by MD's? Perhaps LGND wouldn't discuss this much pending FDA approval.

JO